Gilead Settles HIV Drugs Patent Suit On Eve Of Bench Trial
Gilead Sciences Inc. has settled its Delaware patent infringement lawsuit against five generic-drug makers on the eve of trial, inking a deal that calls for the delayed release until at least...To view the full article, register now.
Already a subscriber? Click here to view full article